Journal of Integrative Oncology

Worldwide, one in eight deaths is due to cancer. Projections based on the GLOBOCAN 2012 estimates predict a substantive increase new cancer cases per year by 2035 in developing countries if preventive measures are not widely applied. According to the World Health Organization (WHO), millions of lives could be saved each year if countries made use of existing knowledge and the best cost-effective methods to prevent and treat cancer. Therefore, the aim of this study is to estimate a provisional budget against cancer in low and middle incomes countries, according the GNI-PPP, the cancer incidence and the number of population. Economically country classification is determining with the Gross national income (GNI), per capita, Purchasing power parity (PPP), according the administrations of the International Monetary Fund (IMF), the World Bank (WB) and the Central Intelligence Agency (CIA). Cancer incidence data presented are based on the most recent data available at IARC. However, population compares estimates from the US Bureau of the Census. The provisional budget is establishing among the guidelines developed by WHO for regional and national cancer control programs according to national economic development. Provisional budget against cancer is estimated to 9,169.203 (thousands of U.S $) for a population of 11,031,386 persons in Somalia.

Breast cancer makes up approximately 25% of all newly diagnosed cancers in women globally and is the second most common cancer in the world today. With the rates of newly diagnosed cancer cases, increasing globally and cancer being amongst the world???s leading cause of death, the question arises, what must the global community do to win the fight against cancer? In order to tackle the issue at hand, the field of oncology care is rapidly evolving with many organizations and institutions investing heavily in various advancing technologies and treatment modalities. With the availability of knowledge and information on different treatment modalities readily available online, many patients are well informed of the treatment options available. However, not all cancer centers are able to provide the most up to date treatment due to financial constraints and often times lack of expertise in niche treatment deliveries. Our industry has reached a point of inflection and the need for integrated collaboration across facilities is more important today than it has ever been. The issue for many facilities is the fear of loss of revenue to competing centers and the lack of ability to invest in the ever-evolving treatment modalities, which can lead to sub-optimal clinical outcomes for the patients. This presentation focuses on the need for integrated collaboration and the importance of working together across facilities as opposed to competing against one another. The discussion centers around three key areas are: (1) Understanding the various treatment modalities, (2) fostering an environment for each group of physicians and their specialties, and (3) building an integrated care network. The various successful models that have been implemented in order to ensure the best clinical outcomes for the patients, giving them access to the latest cutting edge treatment throughout the world will be a part of the presentation.